Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone with finasteride improved muscle and bone health in men with spinal cord injury.

Educators who survived COVID-19 faced physical, psychological, and social challenges but overcame them with resilience and support, highlighting the need for schools to provide better health and psychological care.

Self-amplifying RNA could be a better option for protein replacement therapy with lower doses and lasting effects, but delivering it into cells is still challenging.

The SARS-CoV-2 vaccine may be linked to triggering autoimmune conditions like Alopecia Areata.

Older people with severe COVID-19, especially those with certain health conditions, are more likely to experience post-COVID syndrome.

A woman lost over 80% of her hair due to a condition called telogen effluvium after having COVID-19.

COVID-19 may cause hair loss due to infection stress or treatments.

COVID-19 recovery can lead to temporary hair loss called telogen effluvium.

Over half of the participants in a Saudi Arabian survey experienced hair loss after COVID-19, affecting women and younger people more, with a small percentage feeling a severe impact on their lives.

Some people who recover from COVID-19 continue to have symptoms like fatigue and cough for over 120 days, and some experience hair loss about 59 days after getting sick.

Injecting scalp tissue micrografts is a safe and effective treatment for hair loss after COVID-19.

COVID-19 vaccines do not increase the risk of alopecia areata.

COVID-19 may cause a common type of hair loss called telogen effluvium.

COVID-19 may cause hair loss, often after recovery, with androgenetic alopecia being the most common type.

Changes in gut bacteria can contribute to the development of Polycystic Ovary Syndrome (PCOS), affecting metabolism, immunity, and causing inflammation. Treatments may involve adjusting these factors.

Children generally have milder SARS symptoms than adults, with good outcomes and no deaths reported, but long-term effects are unclear.

Children, especially teenagers, can get severe SARS-CoV infection with symptoms similar to adults, but they typically recover well with supportive care.

After severe COVID-19, lung damage can improve, detected effectively by lung-ultrasound, and high pressure support during hospitalization can increase lung artery size. Also, about 22% of patients had lung blood clots, and when treated, they recovered faster.

Children under 18 had milder SARS with no deaths, but teenagers faced higher severe illness risk, and effective treatments were uncertain.

Many COVID-19 patients have long-term symptoms, especially women, but certain medications may help reduce these symptoms.

COVID-19 may cause different types of hair loss, and the virus's effects on hair could help understand its impact on other body parts.

Many people experienced hair loss after having COVID-19, with the worst cases in hospitalized patients, and some saw hair regrowth within six months.

Different methods, including stress management, healthy diet, supplements, and treatments like minoxidil, can help hair grow back after COVID-19 related hair loss.

COVID-19 can cause significant hair loss.

COVID-19 may cause early hair loss similar to classic temporary hair loss, with further research needed.

COVID-19 can cause hair loss in both severe and mild cases, often affecting women.

Men and women get COVID-19 at similar rates, but men tend to get sicker and have a higher risk of dying, while women usually have stronger immune responses and vaccine reactions.

Using Favipiravir, a COVID-19 treatment drug, likely doesn't cause hair loss.

COVID-19 may cause increased hair loss, but the exact reason is unclear and standard hair loss treatments are recommended.

Dr. SKS hair booster serum effectively treats hair loss caused by COVID-19.